Positive iliac and obturator nodes in melanoma: Survival and prognostic factors

被引:76
作者
Strobbe, LJA
Jonk, A
Hart, AAM
Nieweg, OE
Kroon, BBR
机构
[1] Netherlands Canc Inst, Dept Surg, Antoni Van Leeuwenhoek Ziekenhuis, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Radiotherapy, Antoni Van Leeuwenhoek Ziekenhuis, NL-1066 CX Amsterdam, Netherlands
[3] Canisuis Wilhelmina Ziekenhuis, Dept Surg, Nijmegen, Netherlands
[4] Streekziekenhuis Kon Beatrix, Dept Surg, Winterswijk, Netherlands
关键词
groin dissection; survival; complications; melanoma;
D O I
10.1007/s10434-999-0255-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The need for deep groin dissection when superficial nodes contain metastatic melanoma is controversial. Methods: A review of 362 therapeutic groin dissections performed at our tertiary referral center between 1961 and 1995 revealed 71 patients (20%) with positive iliac and/or obturator nodes. This group was analyzed for survival rates, prognostic factors for survival, regional tumor control, and morbidity. Results: Patients with involved deep nodes exhibited overall 5-year and 10-year survival rates of 24% (SE, 5%) and 20% (SE, 5%), respectively. Independent prognostic factors for survival were the number of positive iliac nodes (P = .0011), the Breslow thickness (P = .0069), and the site of the primary tumor (P = .0075). Patients with an unknown primary tumor seemed to have better prognoses. Seven patients (10%) experienced recurrence in the surgically treated groin. The short- and long-term morbidity rates (infection, 17%; skin flap necrosis, 15%; seroma, 17%; mild/moderate lymphedema, 19%; severe lymphedema, 6%) compared well with those of other series studying inguinal as well as ilioinguinal dissections. Conclusions: From the present study it can be concluded that removal of deep lymph node metastases is worthwhile, because one of every five such patients survives for 10 years. Prognostic factors for survival are the number of involved iliac nodes, the Breslow thickness, and the site of the primary tumor. Long-term regional tumor control can be obtained for 90% of the patients. The morbidity of an additional deep lymph node dissection is acceptable.
引用
收藏
页码:255 / 262
页数:8
相关论文
共 44 条
[1]  
AMES FC, 1985, GROIN DISSECTION, P111
[2]  
BAAS PC, 1992, ARCH SURG-CHICAGO, V127, P281
[3]   Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger [J].
Balch, CM ;
Soong, SJ ;
Bartolucci, AA ;
Urist, MM ;
Karakousis, CP ;
Smith, TJ ;
Temple, WJ ;
Ross, MI ;
Jewell, WR ;
Mihm, MC ;
Barnhill, RL ;
Wanebo, HJ .
ANNALS OF SURGERY, 1996, 224 (03) :255-263
[4]  
BALCH CM, 1992, CUTANEOUS MELANOMA, P165
[5]   OPERATIVE MORBIDITY AND RISK FACTOR ASSESSMENT IN MELANOMA PATIENTS UNDERGOING INGUINAL LYMPH-NODE DISSECTION [J].
BEITSCH, P ;
BALCH, C .
AMERICAN JOURNAL OF SURGERY, 1992, 164 (05) :462-466
[6]   MORBIDITY, MORTALITY AND LOCAL RECURRENCE FOLLOWING REGIONAL NODE DISSECTION FOR MELANOMA [J].
BOWSHER, WG ;
TAYLOR, BA ;
HUGHES, LE .
BRITISH JOURNAL OF SURGERY, 1986, 73 (11) :906-908
[7]   PROGNOSTIC VALUE OF SIZE OF LYMPH-NODE METASTASES IN PATIENTS WITH CUTANEOUS MELANOMA [J].
BUZAID, AC ;
TINOCO, LA ;
JENDIROBA, D ;
TU, ZN ;
LEE, JJ ;
LEGHA, SS ;
ROSS, MI ;
BALCH, CM ;
BENJAMIN, RS .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) :2361-2368
[8]   Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system [J].
Buzaid, AC ;
Ross, MI ;
Balch, CM ;
Soong, SJ ;
McCarthy, WH ;
Tinoco, L ;
Mansfield, P ;
Lee, JE ;
Bedikian, A ;
Eton, O ;
Plager, C ;
Papadopoulos, N ;
Legha, SS ;
Benjamin, RS .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :1039-1051
[9]  
CHANG P, 1982, CANCER-AM CANCER SOC, V49, P1106, DOI 10.1002/1097-0142(19820315)49:6<1106::AID-CNCR2820490607>3.0.CO
[10]  
2-0